• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: RAINDROP NEAR VISION INLAY; IMPLANT, CORNEAL, REFRACTIVE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

RAINDROP NEAR VISION INLAY; IMPLANT, CORNEAL, REFRACTIVE Back to Search Results
Device Problem Unexpected Therapeutic Results (1631)
Patient Problems Dry Eye(s) (1814); Corneal Clouding/Hazing (1878); Headache (1880); Failure of Implant (1924); Nausea (1970); Blurred Vision (2137); Unspecified Eye / Vision Problem (4471)
Event Date 02/11/2022
Event Type  Injury  
Event Description
Raindrop corneal implant was implanted in 2016 when i was having trouble reading small print.After initial improvement my vision deteriorated past the original state.I went to have the implant removed on (b)(6) 2021.I was told that it would take several months for vision to return to what would be normal.I now have cloudy vision in the left eye and cannot use it to read or much of anything else.I am unable to focus my eyes and get continuous headaches, eye aches, dry eye, and nausea, as well as issues with depth perception.Rvo 2.0 inc., (b)(6).Fda safety report id# (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
RAINDROP NEAR VISION INLAY
Type of Device
IMPLANT, CORNEAL, REFRACTIVE
MDR Report Key14592838
MDR Text Key293378992
Report NumberMW5110072
Device Sequence Number1
Product Code LQE
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Patient
Type of Report Initial
Report Date 05/31/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/02/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Was Device Available for Evaluation? No
Patient Sequence Number1
Treatment
2 HEART STENTS ; ASPIRIN ; ATORVASTATIN 80MG TAB ; CLONAZEPAM 1MG TAB AS NEEDED ; CLOPIDOGREL 75MG TAB ; FENOFIBRATE 160MG TAB; FISH OIL ; FLOMAX 0.4MG CAP ; FLUOXETINE 40MG CAP; LISINOPRIL 2.5MG TAB ; MELATONIN ; OXCARBAZEPINE 600MG TAB ; QUETIAPINE FUMARAT 50MG TAB ; VITAMIN D2 (ERGO)50,000IU CAP
Patient Outcome(s) Other; Disability;
Patient Age57 YR
Patient SexMale
Patient Weight113 KG
Patient EthnicityNon Hispanic
Patient RaceWhite
-
-